Intersting article, thanks Eqz. No doubt AI can help assist prediction of DKD/CKD in patients looking at retrospective data.
It’s not a clinical test & it is not looking at individual variations, it can’t replace a Dr/patient relationship or predictive value up to 4 years prior (in that individual patient), diagnosis & disease progression on the basis of pathology tests/clinical signs in individuals. We know that this is where PromarkerD will be a very useful test.
AI could be very useful in data collection & analysis of mass populations in order to target health funding & programmes to prevent/treat CKD/DKD, so a useful tool in population/public health. That’s just IMO.
PIQ Price at posting:
27.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)